Schedule 13G ownership disclosure

CYTOMED THERAPEUTICS LIMITED

Security class unavailable · CUSIP: Y1R80M106

Event date: 2023-04-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
11.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-23-013398
Form type
SC 13G
Filer
CytoMed Therapeutics Ltd
CIK
CIK 1873093
Filed
Apr 24, 2023
Reporting period
Apr 14, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub